Oppenheimer & Co. Inc. Purchases Shares of 11,875 UroGen Pharma Ltd. (NASDAQ:URGN)
Oppenheimer & Co. Inc. acquired a new stake in shares of UroGen Pharma Ltd. (NASDAQ:URGN – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 11,875 shares of the company’s stock, valued at approximately $126,000. Several other […]
Oppenheimer & Co. Inc. acquired a new stake in shares of UroGen Pharma Ltd. (NASDAQ:URGN – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 11,875 shares of the company’s stock, valued at approximately $126,000. Several other […]
